Bausch Health Cos., Inc. (BHC)
6.415
+0.10
(+1.50%)
USD |
NYSE |
Oct 20, 16:00
6.415
0.00 (0.00%)
After-Hours: 20:00
Bausch Health Cos. Price : 6.415 for Oct. 20, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | 6.27 | 6.42 | 6.25 | 6.32 | 1.355M |
| Oct 16, 2026 | 6.35 | 6.385 | 6.20 | 6.30 | 2.193M |
| Oct 15, 2026 | 5.95 | 6.35 | 5.95 | 6.31 | 2.306M |
| Oct 14, 2026 | 5.89 | 6.05 | 5.85 | 5.89 | 1.752M |
| Oct 13, 2026 | 5.91 | 5.92 | 5.732 | 5.89 | 1.558M |
| Oct 12, 2026 | 6.27 | 6.345 | 5.77 | 5.93 | 2.541M |
| Oct 09, 2026 | 6.05 | 6.17 | 6.015 | 6.04 | 1.036M |
| Oct 08, 2026 | 6.14 | 6.200 | 6.02 | 6.04 | 1.268M |
| Oct 07, 2026 | 6.04 | 6.33 | 6.02 | 6.15 | 2.005M |
| Oct 06, 2026 | 5.94 | 6.105 | 5.825 | 6.02 | 3.051M |
| Oct 05, 2026 | 5.73 | 5.96 | 5.71 | 5.89 | 1.473M |
| Oct 02, 2026 | 5.73 | 5.865 | 5.605 | 5.80 | 3.281M |
| Oct 01, 2026 | 5.84 | 5.86 | 5.65 | 5.73 | 1.454M |
| Sep 30, 2026 | 5.83 | 5.925 | 5.72 | 5.83 | 1.458M |
| Sep 29, 2026 | 5.74 | 5.80 | 5.685 | 5.80 | 1.281M |
| Sep 28, 2026 | 5.66 | 5.845 | 5.595 | 5.77 | 1.509M |
| Sep 25, 2026 | 5.66 | 5.83 | 5.63 | 5.69 | 1.250M |
| Sep 24, 2026 | 5.67 | 5.78 | 5.54 | 5.65 | 2.020M |
| Sep 23, 2026 | 5.82 | 5.925 | 5.67 | 5.71 | 1.818M |
| Sep 22, 2026 | 5.755 | 5.82 | 5.615 | 5.81 | 1.913M |
| Sep 21, 2026 | 5.67 | 5.74 | 5.555 | 5.64 | 1.540M |
| Sep 18, 2026 | 5.68 | 5.725 | 5.60 | 5.67 | 1.913M |
| Sep 17, 2026 | 5.78 | 5.78 | 5.625 | 5.65 | 2.865M |
| Sep 16, 2026 | 5.69 | 5.825 | 5.645 | 5.69 | 1.566M |
| Sep 15, 2026 | 5.90 | 5.91 | 5.635 | 5.67 | 1.612M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| InMed Pharmaceuticals, Inc. | 1.34 |
| NervGen Pharma Corp. | 1.545 |
| Milestone Pharmaceuticals, Inc. | 0.7133 |
| Appili Therapeutics, Inc. | 0.0068 |
| Clearmind Medicine, Inc. | 6.04 |
Price Related Metrics
| PS Ratio | 0.2212 |
| Price to Free Cash Flow | 1.743 |
| Earnings Yield | -46.15% |
| Market Cap | 2.399B |
| Operating PE Ratio | 0.8787 |
| Normalized PE Ratio | 11.79 |